Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, and Attending Physician, Pediatric Emergency Medicine, Nemours/Alfred I duPont ...

Nearly 15% of King County children received MMRV as their first measles- or varicella-containing vaccine between 2015 and 2025, a share that did not change despite ACIP's longstanding preference for ...

THRIVE is the first phase 2 study to evaluate the VIASKIN Peanut Patch in infants aged 6 to 12 months with peanut allergy. Investigators will assess whether early epicutaneous immunotherapy can enable ...

THRIVE is the first study to evaluate the VIASKIN Peanut Patch in infants aged 6 to 12 months with confirmed peanut allergy. Investigators hope intervention during infancy may alter the long-term ...

A look back at the latest clinical trial updates for the pediatric population during June 2026. June brought a more concentrated set of clinical trial developments than earlier in the quarter, with ...

The PANDAS/PANS questionnaire is based on symptoms and comorbidities described in the literature and is a self-report completed by parents of children younger than 18. "Bottom line, previous surgery ...

A look back at the FDA approvals, label expansions, and regulatory decisions in the pediatric health care space from April through June 2026. Spring gave way to summer, and along the way the FDA kept ...

Researchers found evidence that childhood influences may contribute to 85 adult health diagnoses, including tobacco use disorder, heart disease, digestive disorders, and urinary conditions. Later age ...

Multiple endocrine-disrupting chemicals were detected in breast milk and infant urine samples from birth through 6 months of age. Bisphenol A, phthalates, parabens, and selected pesticides were among ...

In a parallel regulatory action, the European Medicines Agency has also validated a marketing application for Tivicay covering the neonatal indication. The FDA has accepted a supplemental new drug ...

The FDA has granted Orphan Drug Designation to para-chloro-phenylalanine (pCPA) for monoamine oxidase deficiency (MAOD), a rare X-linked neurodevelopmental disorder associated with impaired monoamine ...

Setmelanotide reduced BMI measures, fat mass, and hyperphagia scores in interim phase 2 Prader-Willi syndrome data. Rhythm Pharmaceuticals reported 6-month interim data from an ongoing phase 2 trial ...